Log in to MyACC
The management of patients with valvular heart disease continues to be transformed by advanced imaging and treatment technologies.
The goals of this solution set are to close gaps in care related to:
- Diagnosis, referral, and treatment patterns
- Access for novel valve replacement procedures for eligible patients
- Regulatory decision-making for transcatheter mitral valve replacement (TMVR) and transcatheter aortic valve replacement (TAVR)
Expert Consensus Decision Pathways
- Management of Conduction Disturbances in Patients Undergoing TAVR (2020)
- Management of Mitral Regurgitation (2020 Focused Update)
- Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention (2019)
- Operator and Institutional Recommendations and Requirements for TAVR (2018)
- Management of Mitral Regurgitation (2017)
- TAVR in Aortic Stenosis Patients (2017)
Appropriate Use Criteria
Clinician Tools
CardioSmart Patient Tools
Aortic Stenosis
- About My Aortic Stenosis
- I Have Aortic Stenosis: Now What?
- Choosing TAVR or Surgery
- Choosing TAVR or Symptom Management
- Heart Valve Disease Infographic
- Heart Valve Disease: Treatment With TAVR Infographic
- Video: Choosing TAVR or Surgery
- Video: Choosing TAVR or Symptom Management
Mitral Regurgitation
Heart House Roundtables
- Tricuspid Valve Disease: Building Frameworks For Success From Clinical and Real-World Advances (2023)
- Emerging Valve Management Strategies (2015 & 2016)
- Optimizing Procedural Standards For Transcatheter Treatment of Mitral Regurgitation and Translating Valve Standards Into Action and Outcomes (2019)
Heart House Patient Forums
- Valvular Heart Disease (2017)
